Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China’s WuXi Commits To Large Expansion Of Research, Reagent Spending

This article was originally published in PharmAsia News

Executive Summary

China's largest drug-research contractor, WuXi PharmaTech, plans to increase spending, perhaps doubling it, on laboratory equipment and reagents and other source materials, the company announced. The spending expansion, from the current $41.7 million, is being done to enlarge its research capacity and support U.S.-based AppTec Laboratory Services, whose $151 million purchase by WuXi just received U.S. Federal Trade Commission approval. To pay for the expansion, WuXi has asked for concessions by its suppliers. (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC066770

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel